
12.02 Delayed Data As of 4:00pm ET | ![]() Today’s Change | 8.75 Today|||52-Week Range 101.39 | +16.93% Year-to-Date |
SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $960.2M |
Novavax, Inc. 21 Firstfield Road Gaithersburg Maryland 20878 |
John C.s Jacobs | President, Chief Executive Officer & Director |
Richard Crowley | Chief Operating Officer & Executive Vice President |
James Patrick Kelly | Chief Financial Officer, Treasurer & Executive VP |
Gale E. Smith | Chief Scientist & Senior Vice President-Discovery |
Gregory M. Glenn | President-Research & Development |